DL-Tyrosine

DL-Tyrosine is a racemic amino acid featuring a phenolic side chain on a chiral α-carbon, paired with a free carboxylic acid and a primary amino group. The aromatic ring with a hydroxyl substituent provides distinct reactivity for electrophilic aromatic substitution, oxidative coupling, and selective protection/deprotection chemistry, while the amino and acid functionalities support standard peptide coupling and salt formation. As a DL (R/S) mixture, it functions as a chiral building block for method development where stereochemical uniformity is not required, and it can also serve as a starting material for resolution strategies or conversion into stereodefined derivatives. The combination of polar amino acid functionality and phenolic side-chain reactivity makes DL-Tyrosine a practical intermediate for amino acid derivatization and downstream synthesis of tyrosine-containing peptides and analogs.

1. Peptide Coupling Building Blocks

DL-Tyrosine is applied in peptide synthesis workflows where tyrosine residues are assembled into linear peptides and protected peptide fragments. The amino group and carboxylic acid enable standard amide bond formation after conversion to appropriately activated forms, while the phenolic side chain can be protected to control chemoselectivity during sequential coupling. Racemic stereochemistry can be retained for method development, library synthesis, or non-stereospecific studies, and subsequent resolution or stereoconvergent transformations may be used when a single enantiomer is required downstream. Tyrosine-derived peptide building blocks prepared from DL-Tyrosine support construction of tyrosine-containing sequences used in biochemical research, analytical reference materials, and synthetic organic chemistry.

2. Side-Chain Functionalization

DL-Tyrosine is used for side-chain derivatization in chemical biology and materials-oriented synthesis, leveraging the phenolic hydroxyl for controlled functional group transformations. The aromatic phenol can be selectively protected to allow orthogonal chemistry at the α-amino/α-carboxyl sites, then deprotected to regenerate a reactive handle for conjugation, oxidation-state tuning, or coupling to electrophiles. Racemic mixtures can be employed in screening contexts where stereochemical outcome is not the primary determinant, such as generating diverse tyrosine-based analogs for structure-activity relationship studies or surface modification precursors. Downstream derivatives derived from DL-Tyrosine can feed into peptidomimetic construction, polymer end-group functionalization, and synthetic intermediate preparation for phenol-bearing bioactive scaffolds.

3. Chiral Resolution And Derivative Synthesis

DL-Tyrosine is utilized as a chiral precursor in processes that require access to stereodefined tyrosine derivatives from a racemate. The presence of a single stereogenic center at the α-carbon enables classical resolution approaches through formation of diastereomeric salts or derivatization to separable intermediates, while the phenolic functionality can be managed via protection to improve selectivity and downstream handling. The resulting stereochemically enriched products can then be converted into N-protected amino acids, activated esters, or peptide coupling-ready forms for stereocontrolled incorporation into longer sequences. This role aligns with chiral amino acid intermediate preparation for research-grade synthesis and process chemistry routes that depend on reliable stereochemical control.

4. Bioconjugation Chemistry

DL-Tyrosine is applied in bioconjugation and biomolecule modification strategies where tyrosine's phenolic group serves as a conjugation locus. The α-amino and carboxyl groups support preparation of linkers, activated intermediates, and spacer units that can be attached to proteins, peptides, or carrier scaffolds, while phenol reactivity can be exploited for coupling chemistries that target the aromatic hydroxyl. Racemic material can be used to generate conjugates for analytical method development, reagent screening, and comparative studies of labeling density or linker architecture without requiring enantiopure stereochemistry. Tyrosine-derived conjugation intermediates prepared from DL-Tyrosine can further support downstream generation of labeled peptides and functional biomolecule constructs used in chemical biology workflows.

5. Pharmaceutical Intermediate Preparation

DL-Tyrosine is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where tyrosine-containing fragments are required for building peptidomimetic or amino acid-based scaffolds. The compound's protected amino acid chemistry supports conversion into N-/C-terminally functionalized derivatives suitable for stepwise assembly, and the phenolic side chain can be protected to prevent side reactions during coupling and purification. Racemic starting material can be used in route scouting, impurity profiling, or intermediate manufacturing steps where stereochemical specification is deferred to later stages such as resolution or stereoselective transformations. Downstream products derived from DL-Tyrosine can serve as chiral synthesis inputs, coupling-ready intermediates, and structural components for SAR studies involving tyrosine analogs.

6. Analytical Standards And Method Development

DL-Tyrosine is employed as a reference material and analytical standard in methods that quantify amino acid composition, monitor derivatization efficiency, or validate chromatographic and spectrometric performance. The combination of amino acid functionality and phenolic aromatic structure enables robust detection after common derivatization strategies, and the racemic nature provides a defined baseline for stereochemistry-agnostic assays. The compound can also be used to prepare calibration mixtures and internal standards for amino acid analysis in peptide synthesis monitoring, process chemistry intermediate characterization, and biochemical research sample workflows. Analytical research use of DL-Tyrosine supports consistent interpretation of derivatization outcomes and supports quality-focused development of amino acid and peptide-related synthetic methodologies.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII